ep0031
sichuan kelun pharma,ellipses
['ep0031', 'lcsm,(-blcsm)', 'solid tumor', 'nsclc', 'sclc']
 kl590586 (a400/ep0031)
a next-generation selective ret inhibitor in patients with ret-altered solid tumors. orr 60% and dcr 95% for all tumor types and doses. in nsclc: orr 81% in 1l and 70% in 2l. also activity proven #asco23 #lcsm 
Medical Oncology 🏥 Hospital General Universitario Gregorio Marañón⎪@myESMO Faculty 🫁 ⎪Power to the patients #endlungcancer #lcsm